Why the study?
Does candesartan improve cardiac and arterial structure and function in hypertensive patients?
Does candesartan improve cardiac and arterial structure and function in hypertensive patients?
Candesartan treatment for 24 weeks significantly reduces left ventricular mass and improves diastolic and arterial function in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
May reduce LVMI in hypertension; hypothesis-generating and requires RCTs before practice change.
Spratt et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: